[1] Busk M, Horsman M R. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine (AIMN) and the International Association of Radiopharmacology (IAR), and Section of the Society of Radiopharmaceutical Sciences, 2013, 57(3): 219-234
[2] Joiner M C, van der Kogel A. Basic Clinical Radiobiology. 4th ed. Abingdon, Oxon: CRC Press, 2009
[3] Howard-Flanders P, Moore D. The time interval after pulsed irradiation within which injury to bacteria can be modified by dissolved oxygen I. A search for an effect of oxygen 0.02 second after pulsed irradiation. Radiation Research, 1958, 9(4): 422-437
[4] Michael B D, Adams G E, Hewitt H B, Jones W B, Watts M E. A posteffect of oxygen in irradiated bacteria: a submillisecond fast mixing study. Radiation Research, 1973, 54(2): 239-251
[5] www.webvidal.ru
[6] Bennewith K L, Durand R E. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity. British Journal of Cancer, 2001, 85(10): 1577-1584
[7] Honess D J, Andrews M S, Ward R, Bleehen N M. Pentoxifylline increases Rif-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion. Acta Oncologica (Stockholm, Sweden), 1995, 34(3): 385-389
[8] Kaanders J H, Bussink J, van der Kogel A J. ARCON: a novel biology-based approach in radiotherapy. The Lancet Oncology, 2002, 3(12): 728-737
[9] liss G B. Oncological specification of a new strain of rat lymphosarcoma. Bulletin of Experimental Biology and Medicine, 1961, 2: 95-99
[10] Orlova A G, Turchin I V, Plehanov V I, Shakhova N M, Fiks I I, Kleshnin M I, Konuchenko N Yu, Kamensky V A. Frequencydomain diffuse optical tomography with single source-detector pair for breast cancer detection. Laser Physics Letters, 2008, 5(4): 321- 327
[11] Maslennikova A V, Orlova A G, Golubiatnikov G Yu, Kamensky V A, Shakhova N M, Babaev A A, Snopova L B, Ivanova I P, Plekhanov V I, Prianikova T I, Turchin I V. Comparative study of tumor hypoxia by diffuse optical spectroscopy and immunohistochemistry in two tumor models. Journal of Biophotonics, 2010, 3 (12): 743-751
[12] De Blasi R A, Cope M, Elwell C, Safoue F, Ferrari M. Noninvasive measurement of human forearm oxygen consumption by near infrared spectroscopy. European Journal of Applied Physiology and Occupational Physiology, 1993, 67(1): 20-25
[13] Lu H, Golay X, Pekar J J, Van Zijl P C M. Sustained poststimulus elevation in cerebral oxygen utilization after vascular recovery. Journal of Cerebral Blood Flow and Metabolism, 2004, 24(7): 764- 770
[14] Zywietz F, B hm L, Sagowski C, Kehrl W. Pentoxifyllin stimuliert die Tumoroxygenierung und Strahlensensibilit t von Rhabdomyosarkomen der Ratte w hrend kontinuierlicher hyperfraktionierter Bestrahlung. Strahlentherapie und Onkologie, 2004, 180(5): 306- 314
[15] McCarty M F, O’Keefe J H, DiNicolantonio J J. Pentoxifylline for vascular health: a brief review of the literature. Open Heart, 2016, 3 (1): e000365
[16] Brown J M, Giaccia A J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research, 1998, 58(7): 1408-1416
[17] Hida K, Maishi N, Torii C, Hida Y. Tumor angiogenesis- characteristics of tumor endothelial cells. International Journal of Clinical Oncology, 2016, 21(2): 206-212
[18] Price M J, Li L T, Tward J D, Bublik I, McBride W H, Lavey R S. Effect of nicotinamide and pentoxifylline on normal tissue and FSA tumor oxygenation. Acta Oncologica (Stockholm, Sweden), 1995, 34(3): 391-395
[19] Moulder J E, RobbinsME C, Cohen E P, Hopewell JW,William F. Ward W F. Pharmacologic modification of radiation-induced late normal tissue injury. In: Mittal B B, Purdy J A, Ang K K, eds. Advances in Radiation Therapy. Berlin: Springer Science & Business Media, 2012, 129-151
